Skip to main content

Scott Leinenweber

Head of Investor Relations

Abbott Laboratories (ABT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.

Get ABT alerts

About Scott Leinenweber

Scott Leinenweber is recorded as Head of Investor Relations at Abbott Laboratories (ABT). Scott Leinenweber has spoken on 12 earnings calls across 1 company, most recently for Abbott Laboratories on April 19, 2023. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Philip P. Boudreau (CFO), Robert E. Funck, Jr. (CFO) and 7 others.

Scott Leinenweber on recent calls

“With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q1 FY2023 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q4 FY2022 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q3 FY2022 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q2 FY2022 Earnings Call ·
“With me today are Robert Ford, Chairman and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer. Robert and Bob will provide opening remarks.”
Head of Investor Relations, Abbott Laboratories Q1 FY2022 Earnings Call ·

Affiliation history

Company network

Leadership on record at Abbott Laboratories

Recent activity